Acadia Pharmaceuticals
ACAD
ACAD
199 hedge funds and large institutions have $3.7B invested in Acadia Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 71 increasing their positions, 60 reducing their positions, and 23 closing their positions.
Holders
199
Holders Change
+13
Holders Change %
+6.99%
% of All Funds
4.31%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
36
Increased
71
Reduced
60
Closed
23
Calls
$33M
Puts
$27.8M
Net Calls
+$5.21M
Net Calls Change
+$3.83M
Top Buyers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$35.6M |
| 2 |
2
D.E. Shaw & Co
New York
|
$38.7M |
| 3 |
3
Artisan Partners
Milwaukee,
Wisconsin
|
$30.4M |
| 4 |
GTC
4
Ghost Tree Capital
New York
|
$24.2M |
| 5 |
5
Franklin Resources
San Mateo,
California
|
$20.1M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
226
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
HT
227
HAP Trading
New York
| – | – | – | – |
|
|
HH
228
HWG Holdings
Houston,
Texas
| – | – | – | – |
|
|
CM
229
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|